Logo Logo Logo Logo Logo
  • HOME
  • ABOUT
    • About Adial
    • Management
    • Board of Directors
  • ADDICTION
    • Alcohol Addiction
    • Limitations of Current AUD Therapies
    • Our Proposed Solution
  • TECHNOLOGY
    • Overview
    • Phase 2b Clinical Trial Results
    • History of Ondansetron Use for AUD
    • Strengths and Competitive Advantages
  • Newsroom
    • Press Releases
    • Media
  • INVESTORS
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • CONTACT
    • Contact Us
    • Sign Up For Email Alerts
  • HOME
  • ABOUT
    • About Adial
    • Management
    • Board of Directors
  • ADDICTION
    • Alcohol Addiction
    • Limitations of Current AUD Therapies
    • Our Proposed Solution
  • TECHNOLOGY
    • Overview
    • Phase 2b Clinical Trial Results
    • History of Ondansetron Use for AUD
    • Strengths and Competitive Advantages
  • INVESTORS
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • CONTACT

Governance Documents

Investor Relations

Investor Relations

  • Overview
  • Analyst Coverage
  • News / Events
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
    • Board Committees
    • Board of Directors
    • Governance Documents

Code of Conduct and Ethics

Download Code of Conduct and Ethics

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Download Nominating and Corporate Governance Committee Charter

©Adial Pharmaceuticals 2022